Inpharma Weekly

, Volume 1233, Issue 1, pp 11–11 | Cite as

Prolonging antiandrogen therapy appears to improve survival duration in patients with stage D2 prostate cancer

Clinical study
  • 3 Downloads

Keywords

Prostate Cancer Androgen Flutamide Goserelin Bicalutamide 

Copyright information

© Adis International Ltd 2000

Personalised recommendations